BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for ELI LILLY AND COMPANY · Pharmaceuticals

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Indiana · House · Senate · $90,000.00 income · posted Jul 20, 2026

Lobbying activity 2

Health Issues

Issues related to biotechnology legislation Diagnostic tests Clinical trial issues Issues related to supply chain

Pharmacy

Issues related to the pharmaceutical industry Treat and Reduce Obesity Act Pharmaceutical tariffs Safe Drugs Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.